Qiming, Hillhouse Lead $55M Series C Round In Chinese Biotech Firm Jacobio Pharmaceuticals

Login to View

Qiming Capital and Hillhouse Capital have led a US$55 million series C round in Jacobio Pharmaceuticals, a Beijing-based clinical stage biotech company. 

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info

Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in